These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 18308169)

  • 1. Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents.
    Bansal D; Sachdeva R; Mehta JL
    J Am Coll Cardiol; 2008 Mar; 51(9):970-1; author reply 971-2. PubMed ID: 18308169
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous treatment of diseased saphenous vein grafts: current state-of-the-art and future directions.
    Vermeersch P; Agostoni P
    Minerva Cardioangiol; 2007 Oct; 55(5):637-46. PubMed ID: 17912167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond embolic protection for saphenous vein graft disease.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
    [No Abstract]   [Full Text] [Related]  

  • 4. Revitalizing embolic protection in saphenous vein grafts.
    Satler LF
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):270-1. PubMed ID: 20665876
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of drug-eluting stents in venous coronary artery bypass grafts.
    Hernandez-Antolín R; Alfonso F; Jimenez P
    EuroIntervention; 2009 May; 5 Suppl D():D51-7. PubMed ID: 19736072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long drug-eluting stent implantation for a diffusely diseased right internal mammary artery.
    Niccoli G; Biscione C; Conte M; Crea F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):381-3. PubMed ID: 17443108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna registry).
    Vignali L; Saia F; Manari A; Santarelli A; Rubboli A; Varani E; Piovaccari G; Menozzi A; Percoco G; Benassi A; Rusticali G; Marzaroli P; Guastaroba P; Grilli R; Maresta A; Marzocchi A
    Am J Cardiol; 2008 Apr; 101(7):947-52. PubMed ID: 18359313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal therapy for degenerated saphenous vein graft disease.
    Kramer B
    J Invasive Cardiol; 1995; 7 Suppl D():14D-20D. PubMed ID: 10155126
    [No Abstract]   [Full Text] [Related]  

  • 9. The unrelenting challenge of vein graft disease.
    Hermiller JB
    J Invasive Cardiol; 2010 Jun; 22(6):258-9. PubMed ID: 20516503
    [No Abstract]   [Full Text] [Related]  

  • 10. Should bare metal or drug-eluting stents be used during PCI of saphenous vein graft lesions: waiting for Godot?
    Brilakis ES; Berger PB
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):815-8. PubMed ID: 19006238
    [No Abstract]   [Full Text] [Related]  

  • 11. DES in saphenous bypass grafts: A treatment in vain?
    Hillegass WB
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):21-2. PubMed ID: 18561144
    [No Abstract]   [Full Text] [Related]  

  • 12. DES for SVG stenosis -- we all want to do it, but are we there yet?
    Smith CS; Yeghiazarians Y
    J Invasive Cardiol; 2007 Oct; 19(10):410-1. PubMed ID: 17906341
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-eluting stent in saphenous vein graft lesions.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
    [No Abstract]   [Full Text] [Related]  

  • 14. Double jeopardy, double trouble.
    Blankenship JC
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):279-80. PubMed ID: 20665877
    [No Abstract]   [Full Text] [Related]  

  • 15. Embolic protection devices in saphenous vein graft interventions.
    Cragun DT; Heuser RR
    J Interv Cardiol; 2006 Dec; 19(6):525-9. PubMed ID: 17107367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical impact of atherosclerotic saphenous vein to coronary artery bypass grafts.
    Lytle BW
    Semin Thorac Cardiovasc Surg; 1994 Apr; 6(2):81-6. PubMed ID: 8025142
    [No Abstract]   [Full Text] [Related]  

  • 17. Paclitaxel-eluting stents for chronically occluded saphenous vein grafts (EOS) study.
    Jim MH; Ho HH; Ko RL; Siu CW; Yiu KH; Lau CP; Chow WH
    J Interv Cardiol; 2010 Feb; 23(1):40-5. PubMed ID: 20465719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intragraft nicardipine prophylaxis to prevent no-reflow in triple-vessel saphenous vein graft intervention.
    Fischell T; Haller S; Ashraf K
    J Invasive Cardiol; 2005 Jun; 17(6):334-7. PubMed ID: 16003012
    [No Abstract]   [Full Text] [Related]  

  • 19. Percutaneous treatment of saphenous vein bypass graft obstructions: a continuing obstinate problem.
    de Feyter PJ
    Circulation; 2003 May; 107(18):2284-6. PubMed ID: 12742967
    [No Abstract]   [Full Text] [Related]  

  • 20. Myocardial infarction in saphenous percutaneous intervention: are we really doing our best?
    Lozano I; Rondan J; Avanzas P
    Am Heart J; 2009 Sep; 158(3):e39; author reply e41. PubMed ID: 19699850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.